Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Gastrointestinal Drugs Market Trend, Segmentation And Industry Analysis Research Report 2018

 



(Medical-NewsWire.com, February 16, 2018 )
The Global Gastrointestinal Drug Market is expected to grow at CAGR of 4.8% during forecasted period 2017- 2023. It is estimated to reach till USD $ 59.3 billion by end of 2024.
Gastrointestinal (GI) disease affects stomach, large intestine and rectum, small intestine, esophagus, liver, gallbladder and pancreas. The symptoms of GI diseases are heartburn, indigestion, bloating, constipation and many more. According to a report by the World Gastroenterology Organization, 35-40 % of world’s total population is suffering from acute or chronic GI complication. Increasing patient having GI diseases and disorders, due to change in dietary pattern are the major factor for increasing the global GI drug market. The exact cause for inflammatory bowel disease and Irritable bowel syndrome are still unknown due to which permanent cure for this disease is not available which may restrain the growth of the market.
Key Players for Global Gastrointestinal Drugs market: AbbVie Inc. (US), AstraZeneca (UK), Johnson & Johnson (US), Valeant (US), Abbott Laboratories(US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals (US), Sanofi (France), Janssen Biotech (US), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany).
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/558 .
Global Gastrointestinal Drugs Market has been segmented on the basis of Drug Category they are segmented into Acid Neutralizers, Laxatives and Antidiarrheal, antiemetic, Anti-inflammatory drugs and other. By Route of Administration they are segmented into Oral, Parenteral and rectal. By disease Type they are Gastroesophageal Reflux Disease, Inflammatory Bowel Disease and Other. And by End User Hospital Pharmacies, Retail Pharmacies and Other.
Acid Neutralizers which are further sub segmented into Antacids, H2 antagonists, Proton pump inhibitors and Others,
Regional Analysis
North America, Europe, Asia Pacific and Middle East and Africa are the four major regional segment of global GI drugs market.. North America account for the largest market share for the global gastrointestinal drug market. Increasing geriatric population is the major driving factor for the market of GI drugs in North America. Europe and Asia Pacific share nearly similar amount of market. Introduction of new drugs and different technology has increased the market in Asia Pacific and Europe. Asia Pacific is the most favourable region for the development of GI drug market. Huge population and infrastructural improvement has increases the scope for the development of this market in coming future.
Table of Contents
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Gastrointestinal Drugs Market, By Drug Category
6 Global Gastrointestinal Drugs Market, By Route Of Administration
7 Global Gastrointestinal Drugs Market, Disease Type
8 Global Gastrointestinal Drugs Market
9 Global Gastrointestinal Drugs Market, By Region
10 Competitive Landscape
11 Company Profile
… Toc Continued
Ask Question to Expert @ https://www.marketresearchfuture.com/enquiry/558 .
Top 5 Reasons to Buy the Reports:
• Company profiling with detailed strategies, financials, and recent development activities
• Market Strategic Business Influence Data
• Market Research Future recommendations in key business segments based on the market estimations
• Market share analysis of the top industry players
• Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com


Marketresearchfuture

Market Research Future

+1 (646) 845 9349

sales@wiseguyreports.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com ™ - Medicl Newswire and Press Release service of GroupWeb Media LLC